STRATA Skin Sciences to Participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, has announced its participation in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference. The event is scheduled for August 12-13, 2024.
Key points:
- Dr. Dolev Rafaeli, President and CEO, and Christopher Lesovitz, CFO, will represent STRATA
- They will be available for one-on-one meetings on both conference days
- Investors can arrange meetings by contacting IR@strataskin.com
This participation demonstrates STRATA's commitment to engaging with investors and showcasing their innovative dermatologic products and technologies.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), un'azienda di tecnologia medica focalizzata sul trattamento dermatologico, ha annunciato la sua partecipazione alla 9a Conferenza Virtuale Annuale Needham MedTech & Diagnostics 1x1. L'evento si svolgerà il 12-13 agosto 2024.
Punti chiave:
- Il Dr. Dolev Rafaeli, Presidente e CEO, e Christopher Lesovitz, CFO, rappresenteranno STRATA
- Saranno disponibili per incontri individuali in entrambi i giorni della conferenza
- Gli investitori possono organizzare incontri contattando IR@strataskin.com
Questa partecipazione dimostra l'impegno di STRATA a interagire con gli investitori e a mostrare i loro innovativi prodotti e tecnologie dermatologiche.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), una empresa de tecnología médica enfocada en tratamientos dermatológicos, ha anunciado su participación en la 9ª Conferencia Virtual Anual Needham MedTech & Diagnostics 1x1. El evento está programado para el 12-13 de agosto de 2024.
Puntos clave:
- El Dr. Dolev Rafaeli, Presidente y CEO, y Christopher Lesovitz, CFO, representarán a STRATA
- Estarán disponibles para reuniones individuales en ambos días de la conferencia
- Los inversores pueden organizar reuniones contactando a IR@strataskin.com
Esta participación demuestra el compromiso de STRATA por interactuar con los inversores y mostrar sus productos y tecnologías dermatológicas innovadoras.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN)는 피부과 치료에 중점을 둔 의료 기술 회사로, 제9회 연례 가상 니드햄 메드텍 & 진단 1x1 컨퍼런스에 참여할 것이라고 발표했습니다. 이 행사는 2024년 8월 12-13일에 예정되어 있습니다.
주요 내용:
- 드롤레프 라파엘리 사장 겸 CEO와 크리스토퍼 레소비츠 CFO가 STRATA를 대표합니다.
- 그들은 컨퍼런스 양일간 일대일 미팅을 위한 시간을 가질 수 있습니다.
- 투자자들은 IR@strataskin.com으로 연락하여 미팅을 예약할 수 있습니다.
이번 참여는 투자자와의 소통과 혁신적인 피부과 제품 및 기술을 소개하려는 STRATA의 의지를 보여줍니다.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), une entreprise de technologie médicale axée sur les traitements dermatologiques, a annoncé sa participation à la 9e Conférence Virtuelle Annuelle Needham MedTech & Diagnostics 1x1. L'événement est prévu pour les 12-13 août 2024.
Points clés :
- Le Dr Dolev Rafaeli, Président et CEO, et Christopher Lesovitz, CFO, représenteront STRATA
- Ils seront disponibles pour des réunions individuelles lors des deux jours de la conférence
- Les investisseurs peuvent organiser des réunions en contactant IR@strataskin.com
Cette participation démontre l'engagement de STRATA à interagir avec les investisseurs et à présenter ses produits et technologies dermatologiques innovants.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), ein Medizintechnikunternehmen, das sich auf dermatologische Behandlungen konzentriert, hat seine Teilnahme an der 9. jährlichen virtuellen Needham MedTech & Diagnostics 1x1 Konferenz bekannt gegeben. Die Veranstaltung ist für 12.-13. August 2024 angesetzt.
Wichtige Punkte:
- Dr. Dolev Rafaeli, Präsident und CEO, sowie Christopher Lesovitz, CFO, werden STRATA vertreten
- Sie stehen an beiden Konferenztagen für persönliche Gespräche zur Verfügung
- Investoren können Meetings vereinbaren, indem sie IR@strataskin.com kontaktieren
Diese Teilnahme zeigt STRATAs Engagement für die Interaktion mit Investoren und die Präsentation ihrer innovativen dermatologischen Produkte und Technologien.
- None.
- None.
HORSHAM, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference being held on August 12 – 13, 2024.
Dr. Rafaeli and Mr. Lesovitz will be available for one-on-one meetings on both days of the conference. Investors can also contact IR@strataskin.com to arrange a meeting.
About STRATA Skin Sciences
STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as psoriasis, vitiligo, and acne. Its products include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System.
STRATA is proud to offer these exciting technologies in the U.S. through its unique Partnership Program. STRATA’s popular partnership approach includes a fee per treatment cost structure (versus an equipment purchase), installation and use of the device, on-site training for practice personnel, service and maintenance of the equipment, dedicated account and customer service associates, and co-op advertising support to help raise awareness and promote the program within the practice.
Safe Harbor
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to the Company’s plans, objectives, expectations and intentions and may contain words such as “will,” “may,” “seeks,” and “expects,” that suggest future events or trends. These statements, the Company’s ability to launch and sell products recently acquired or to be developed in the future, the Company’s ability to develop social media marketing campaigns, direct to consumer marketing campaigns, and the Company’s ability to build a leading franchise in dermatology and aesthetics, are based on the Company’s current expectations and are inherently subject to significant uncertainties and changes in circumstances. Actual results may differ materially from the Company’s expectations due to financial, economic, business, competitive, market, regulatory, adverse market conditions labor supply shortages, or supply chain interruptions resulting from fiscal, political factors, international conflicts, responses, or conditions affecting the Company, the medical device industry and our customers and patients in general, as well as more specific risks and uncertainties set forth in the Company’s SEC reports on Forms 10-Q and 10-K. Given such uncertainties, any or all these forward-looking statements may prove to be incorrect or unreliable. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not undertake any obligation to update or revise these statements to reflect events or circumstances occurring after the date of this press release. The Company urges investors to carefully review its SEC disclosures available at www.sec.gov and www.strataskinsciences.com.
Investor Contact:
CORE IR
516-222-2560
IR@strataskin.com
FAQ
When is STRATA Skin Sciences (SSKN) participating in the Needham MedTech & Diagnostics Conference?
Who will represent STRATA Skin Sciences (SSKN) at the Needham Conference?
How can investors arrange meetings with STRATA Skin Sciences (SSKN) during the Needham Conference?
What is the focus of STRATA Skin Sciences (SSKN) as a company?
